S:X}<>5TYQI/D807Z,~$~TZT$YCSDP
SYSTEM PROCESSING...
S:X}<>5TYQI/D807Z,~$~TZT$YCSDP
SYSTEM PROCESSING...
Posted: 2025-05-31 12:39:47 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-31 12:40:04 UTC
Verified By
Rollup News
China's pharmaceutical industry is making significant strides in cancer research, challenging the dominance of American companies at the American Society of Clinical Oncology's annual meeting. Chinese firms like Akeso are presenting groundbreaking trial results, leading to increased investment from major pharmaceutical companies like GSK, AstraZeneca, and Merck.
Chinese pharmaceutical innovation in cancer treatment
Increased investment in Chinese drug companies by global pharma giants
Shifting landscape of cancer research and development
Akeso's successful trial results for lung cancer drug
Overcoming the perception of "copycat" drugs
Competition with established American pharmaceutical companies